The results show that from 2013 to 2017, the field’s attention has been directed toward studying the application of the keto diet in the treatment of epilepsy, including metabolic disorders that can cause wiring (e.g., GLUT1 deficiency and pyruvate dehydrogenase deficiency). This evidence concerns the gene SLC2A1 and metabolic disease.